GRI Bio, Inc. (GRI): Nasdaq/NYSE listing notice — GRI Bio receives Nasdaq delisting notice for failing stockholders' equity requirement

GRI Bio, Inc.

Notice received Nov 22, 2023 for non-compliance with Nasdaq Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity.
Stockholders' equity fell below $2.5M as of September 30, 2023 based on Q3 10-Q.
Company must submit a compliance plan by January 6, 2024 to avoid potential delisting.
If plan accepted, Nasdaq may grant up to 180 calendar days extension to regain compliance.
No immediate effect on trading but risk of delisting if compliance plan is rejected.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GRI Bio, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

November 22, 2023, GRI Bio, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market (the “Notice”) based on the information provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023. Nasdaq Listing Rule 5550(b)(1) requires that companies listed on The Nasdaq Capital Market with a market value of listed securities of less than

View on SEC.gov

Browse all listing & compliance notices →

GRI Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001824293-23-000175

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.